Question : Number of People affected due to COVID-19

a) the number of people traced, tested, treated/recovered and died including doctors, medical practitioners and frontline workers in the country so far since the outbreak of COVID-19 pandemic in the country, State/UT and year-wise;
b) the number of persons vaccinated in the country including provision of booster doses so far as also one/two doses, State/UT-wise including 12 to 18 years and below 12 years age group;
c) the status of production, availability, export and shortage of COVID-19 vaccines in the country;
d) whether there is any possibility of the resurgence of the coronavirus pandemic in the near future and if so, measures taken/proposed to be taken to prevent any future outbreak of the pandemic;
e) whether any instructions have been issued to the State Governments in this regard, and
f) if so, the details thereof and if not, the reasons therefor?

THE MINISTER OF STATE IN THE MINISTRY OF HEALTH & FAMILY WELFARE
(DR BHARATI PRAVIN PAWAR)

(a) to (f): The details of tests, cases, treated/recovered and deaths as reported by States/UTs as on 19th July 2022 are at Annexure I, II and III respectively.
As on 19th July 2022, a total of 200.34 crore COVID-19 vaccine doses have been administered to beneficiaries above 12 years of age. State/UT wise details on vaccine doses administered in 12-18 years’ age group and vaccine doses administered in 18 years and above age group are Annexure IV and Annexure V respectively. COVID-19 vaccination below 12 years of age has not begun in National Covid Vaccination Programme.
Currently, five COVID-19 vaccines are being used under the vaccination program namely Covishield, Covovax, Covaxin, Sputnik V vaccine and Corbevax. Adequate COVID-19 vaccine doses have been made available to all States/UTs to vaccinate all eligible beneficiaries. As on 15th July 2022, India has supplied 23.9 crore doses of COVID-19 vaccine to 101 countries and UN entities in the form of grant, commercial export or through COVID-19 Vaccines Global Access (COVAX).
Given the emergence of variants of COVID-19 virus with variable transmissibility and other public health implications, Union Ministry of Health is following COVID-19 trajectory globally and in the country along with various Expert Committees. In addition, network of Indian SARS-CoV-2 Genomics Consortium (INSACOG) of laboratories is taking whole genome sequencing of samples for detection of mutant variants of the virus.
Union Ministry of Health provides requisite support to States/UTs to enhance preparedness and response capacities against COVID-19. Funding support has been provided to States/UTs for health system strengthening to meet any exigency due to resurgence of cases in the country through National Health Mission, State Disaster Response Funds (SDRF), Emergency COVID-19 Response and Preparedness packages and PM - Ayushman Bharat Health Infrastructure Mission.
***